www.fdanews.com/articles/145930-amgen-buying-turkey-rsquo-s-mustafa-nevzat-for-700-million

Amgen Buying Turkey’s Mustafa Nevzat for $700 Million

April 26, 2012

Amgen is buying Turkish pharmaceutical company Mustafa Nevzat Pharmaceuticals for $700 million as part of its international expansion plans.
Businessweek